NPI: 1043271414 · OCEAN SPRINGS, MS 39564 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 03/28/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 03/28/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 12,854 | $219K |
| 2019 | 14,107 | $233K |
| 2020 | 19,500 | $246K |
| 2021 | 13,084 | $183K |
| 2022 | 9,330 | $207K |
| 2023 | 5,026 | $258K |
| 2024 | 3,328 | $273K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 27,515 | 2,712 | $1.26M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 22,299 | 1,324 | $277K |
| 83970 | 1,457 | 1,206 | $33K | |
| J1756 | Injection, iron sucrose, 1 mg | 4,941 | 1,314 | $15K |
| 82108 | 450 | 369 | $7K | |
| 82728 | 777 | 643 | $7K | |
| A4657 | Syringe, with or without needle, each | 3,199 | 1,680 | $5K |
| J1270 | Injection, doxercalciferol, 1 mcg | 11,313 | 1,039 | $4K |
| 83550 | 657 | 538 | $4K | |
| 83540 | 805 | 649 | $3K | |
| 85041 | 1,530 | 1,291 | $3K | |
| 85048 | 1,527 | 1,287 | $2K | |
| 90674 | 97 | 76 | $741.60 | |
| 90662 | 25 | 25 | $392.07 | |
| 0011A | 31 | 14 | $84.05 | |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 187 | 94 | $0.00 |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 347 | 214 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 72 | 55 | $0.00 |